Premature ovarian failure
Premature ovarian failure (FOP) is defined as the cessation of ovarian activity at a young age, which means that the ovaries stop functioning before the menopausal age. Therefore, the woman stops ovulating and her blood estrogen levels decrease.
Below you have an index with all the points that we will discuss in this article.
Index
Premature ovarian failure- 1. Causes and symptoms
- 2. Diagnosis and treatment
- 3. Consequences in fertility
- 4. Authors and collaborators
Early ovarian failure occurs in 1 in 100 women under 40 and in 1 in 1,000 women under 30 years of age.
Ovarian differentiation begins around the eighth week of gestation, so that by week 20 of gestation there is already a number close to 6-7 million oogonias, the stem cells that will give rise to the ovules.
These oogonia will go atresiando (dying) and their number will decrease until the moment of birth. At the time of puberty there will be about 300,000 ovules that will be released in the menstrual cycles during the reproductive life.
Ovodonation by FOPIn theory, women have at birth a sufficient number of ovules to release at least until they are 50 years old.
Thus, when there is a cessation of menstruation due to follicular exhaustion of the ovary before the age of 40, or if there is a lack of response of the ovarian follicles to the hormonal stimuli of the gonadotropins during an assisted reproduction treatment , we will discuss premature ovarian failure.
Causes and symptoms
The causes that originate the FOP can be several and sometimes difficult to know, among them we can find:
- Genetic disorders (X-fragile syndrome, Turner syndrome, etc.).
- Exposure to toxic substances such as chemotherapy and radiation.
- Enzymatic or metabolic defects (galactosemia, hemochromatosis, etc.).
- Diseases such as anorexia nervosa, diabetes, pernicious anemia and lupus.
- Infections due to Herpes Zoster or cytomegalovirus.
However, in most cases the cause is unknown, although if there is a direct family history there may be a greater chance of developing early ovarian failure.
Some of the symptoms that may occur are:
- Irregular rules or absence of menstruation
- Night sweats
- Vaginal dryness
- Hot flushes or hot flashes
- Insomnia
- Irritability and susceptibility
- Lack of sexual desire
- Difficulty of concentration
- Fertility problems
In general, the symptoms are usually similar to those of menopause and are due to low levels of estrogen.

Diagnosis and treatment
The diagnosis is made through an analysis of the previous clinical history along with a physical and gynecological examination.
Diagnosis of FOPFor the confirmation of the syndrome an analysis of the hormones FSH and 17?-estradiol is carried out. An elevated FSH and low estradiol will confirm the evidence of ovarian failure.
If the ovarian failure has no apparent reason, a blood test can be performed to study the karyotype (chromosomes).
The treatment of FOP will depend on the woman's symptoms and whether there are health risks such as osteoporosis or heart disease caused by low levels of estrogen.
Substitute hormone therapy, using pills or patches of estrogen and progesterone, is the most used because it relieves menopausal symptoms and helps to combat bone loss caused by osteoporosis.
For those women who do not want to conceive, the combined contraceptive pill can also be a solution.

Consequences on fertility
Due to the lack of ovulation and low levels of estrogen, it is very common to have infertility. In these cases ovarian stimulation for in vitro fertilization treatment with own ovules is not usually effective.
However, in 5-10% of cases a pregnancy can be achieved if the alteration is not permanent and the ovary can have some activity. For this the ovarian failure must be spontaneous and the karyotype is normal, although there is no way of knowing if this will happen.
If the ovarian stimulation does not have the desired effect, the recommended assisted reproduction technique would be the donation of ovules.

Authors and collaborators
Teresa Rubio Asensio EmbriólogaMaster University in Reproductive Medicine and Genetics by the Miguel Hernández University of Elche (UHM). Professor of Clinical Embryology courses at the UHM. Member and editor of scientific contents in ASEBIR and ASPROIN. Embryologist specialist in Reproductive Medicine in UR Virgen de la Vega. More information.autor_box {background-color: #ececec; padding: 20px 30px; font-size: 14px;} .author_name {font-size: 18px; font-weight: bold; margin-bottom: 5px;} .author_title {font-weight: bold;} .author_text {margin-bottom: 10px;} .autor_box_izq {display: inline-block; vertical-align: middle; width: 15%;}. author_box_dcha {display: inline-block; vertical-align: middle; width: 85%;}. author_box_dcha_sep {margin: 0 0 10px 30px} .author_box_descripcion {margin-top: 0px; text-align: right;} .autor_box_descripcion_sep {display: inline-block; width: -moz-calc (85% - 30px); width: -webkit-calc (85% - 30px); width: -o-calc (85% - 30px); width: calc (85% - 30px); text-align: left;}. author_box: not (: last-child) {margin-bottom: 20px} @media screen and (max-width: 470px) {.autor_box {font -size: 16px; padding: 20px;} .author_name {font-size: 16px; margin-bottom: 3px;} .autor_box_izq {width: 20%;} .autor_box_dcha {width: 80%;} .autor_box_dcha_sep {margin: 0 0 10px 20px} .author_box_descripcion {margin-top: 10px} .autor_box_descripcion_sep {width: 100%}}
Comments
Post a Comment